Abstract
Immunometabolism is an emerging field of investigation at the interface between the historically distinct disciplines of immunology and metabolism. Accelerating interest in this area is being fuelled by the obesity epidemic and the relatively recent realization that obesity affects the immune system and promotes inflammation, and that obesity-induced inflammation potentially promotes a variety of chronic conditions and diseases. The multilevel interactions between the metabolic and immune systems suggest pathogenic mechanisms that may underlie many of the downstream complications of obesity and offer substantial therapeutic promise.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
Nature Communications Open Access 13 October 2023
-
Leptin/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages
Molecular Medicine Open Access 24 July 2023
-
Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection
Communications Biology Open Access 07 April 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nature Rev. Immunol. 11, 85–97 (2011).
Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nature Rev. Immunol. 11, 98–107 (2011).
Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007).
Ouchi, N. et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454–457 (2010).
Larsen, C. M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517–1526 (2007).
Larsen, C. M. et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 32, 1663–1668 (2009).
Goldfine, A. B. et al. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin. Transl. Sci. 1, 36–43 (2008).
Fleischman, A., Shoelson, S. E., Bernier, R. & Goldfine, A. B. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31, 289–294 (2008).
Goldfine, A. B. et al. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346–357 (2010).
Finlay, D. & Cantrell, D. A. Metabolism, migration and memory in cytotoxic T cells. Nature Rev. Immunol. 11, 109–117 (2011).
Nakada, D., Saunders, T. L. & Morrison, S. J. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468, 653–658 (2010).
Gurumurthy, S. et al. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468, 659–663 (2010).
Gan, B. et al. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468, 701–704 (2010).
Gallagher, E. J. & LeRoith, D. Insulin, insulin resistance, obesity, and cancer. Curr. Diab. Rep. 10, 93–100 (2010).
Rothwell, P. M. et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377, 31–41 (2010).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Diane Mathis is a member of the Scientific Advisory Boards of Tempero Pharmaceuticals and Catabasis Pharmaceuticals Inc.
Steven E. Shoelson holds patents on the use of salicylates in diabetes, prediabetes and cardiovascular disease. He has consulted for Catabasis, Amylin, AstraZeneca, Merck, Genentech, XOMA and Kowa
Rights and permissions
About this article
Cite this article
Mathis, D., Shoelson, S. Immunometabolism: an emerging frontier. Nat Rev Immunol 11, 81–83 (2011). https://doi.org/10.1038/nri2922
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri2922
This article is cited by
-
Macrophage and T cell networks in adipose tissue
Nature Reviews Endocrinology (2024)
-
Leptin/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages
Molecular Medicine (2023)
-
Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection
Communications Biology (2023)
-
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges
Nature Reviews Cardiology (2023)
-
A new technique to study nutrient flow in host-parasite systems by carbon stable isotope analysis of amino acids and glucose
Scientific Reports (2023)